|
HS Code |
286577 |
| Productname | 2-Bromo-3-Chloro-5-Fluorotoluene |
| Molecularformula | C7H5BrClF |
| Molecularweight | 223.47 g/mol |
| Casnumber | 132346-25-1 |
| Appearance | Colorless to pale yellow liquid |
| Boilingpoint | 221-223°C |
| Density | 1.62 g/cm³ |
| Purity | Typically >= 98% |
| Synonyms | 2-Bromo-3-chloro-5-methylfluorobenzene |
| Smiles | Cc1cc(F)c(Cl)cc1Br |
| Refractiveindex | 1.582 |
| Flashpoint | 96°C |
| Solubility | Insoluble in water, soluble in organic solvents |
As an accredited 2-Bromo-3-Chloro-5-Fluorotoluene factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Bromo-3-Chloro-5-Fluorotoluene prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Walk through any modern synthetic chemistry lab, and the real success stories often go unnoticed among the racks of glassware and reagents: tightly specified building blocks powering new inventions. Among this new generation of specialty chemicals, 2-Bromo-3-Chloro-5-Fluorotoluene stands out for its role in driving reliable, step-wise synthesis—particularly in the pharmaceutical and agrochemical sectors. Its molecular composition—featuring a bromo group on the benzene ring, joined by both chloro and fluoro substituents and a methyl at the right spot—translates into a compound with strong selectivity in coupling reactions and cross-functional processes. It’s not just about structure. Results matter. Labs turn to this compound for predictable, repeatable reactivity in challenging reactions, whether scouting early-stage leads or working up to scale production.
Working with halogenated toluenes, the question is less about broad category and much more about ratio, geometry, and purity. 2-Bromo-3-Chloro-5-Fluorotoluene puts the bromo at the ortho position (relative to methyl), with a chloro at meta and a fluoro at para. This layout isn’t just for theory—it shapes every practical step, affecting which reactions are possible and how the compound behaves as a partner. Formulaic listings (C7H5BrClF, molecular weight 223.48 g/mol) only tell a portion of the story; more important is the way this mix of halogens turns a simple toluene derivative into a cornerstone intermediate for Suzuki, Stille, and Heck reactions.
Chemists—myself included—know that the biggest headaches often come from unpredictable side products and competing reactivity. Consistent, high-purity supply makes a difference. 2-Bromo-3-Chloro-5-Fluorotoluene is expected to show a purity of 98 percent or higher, with strict GC and NMR analysis standards. These benchmarks aren’t arbitrary. A stray percent of impurity can sink an otherwise promising process or, worse, introduce toxic byproducts with real downstream concerns. The best suppliers will back lots with certificates of analysis, so researchers aren’t left doubting what goes in the flask.
Take real-world medicinal chemistry. Early programs revolve around exploring small differences in structure—swapping a fluorine here, a chlorine there. That’s where this compound comes into its own. Fluorine atoms, with their high electronegativity, can improve metabolic stability in drug candidates, while the bulky bromo and chloro add options for further elaboration. In practical terms, 2-Bromo-3-Chloro-5-Fluorotoluene serves as a launchpad for dozens of custom ligands, active pharmaceutical ingredients (APIs), and crop protection compounds.
Synthetic routes favor it for Suzuki-Miyaura cross-coupling, where bromo serves as a highly reactive leaving group. The chloro and fluoro, being less reactive under many coupling conditions, provide “handles” for stepwise derivatization. It’s like Lego for chemists: the bromo comes off first, leaving the other halogens for later manipulation under more forcing or selective conditions, giving much greater access to novel scaffolds. Graduate students and industry teams prize this trait when patent space feels crowded and every new analog could open a path to a better candidate.
Not every halogenated toluene behaves the same. The difference isn’t subtle when you’re sitting up late, tracking TLC spots under UV. Mono-halogenated versions like 2-bromotoluene are easier to make, but they’re much less versatile. Add a second or third halogen, and the molecule jumps in complexity—and utility. Products like 2-Bromo-3-Chloro-5-Fluorotoluene are anything but generic: the positions of each halogen control both electronic and steric interactions, flipping the reactivity compared to, say, 4-bromo-3-chlorotoluene.
In my own work, using single-halogenated toluenes meant choosing between reactivity and selectivity. Dual or triple halogen variants let us steer reactions with greater control. The added fluorine does more than just take up space; it affects dipole moment and sometimes makes the ring less electron-rich, shifting reaction pathways—often towards the desired products with less waste. This compound helps researchers avoid one-pot lottery chemistry, which saves material, time, and patience.
Commercially available analogs vary as well. Some variants combine halogens at ortho-para, others at meta-meta; small shifts in position can make a night-and-day difference for synthetic utility. 2-Bromo-3-Chloro-5-Fluorotoluene's arrangement covers a unique sweet spot—not too hindered, but reactive enough where you want it. That's what separates it from broader classes and why process chemists—even far removed from the bench—pay attention to each exocyclic group.
Few things derail a drug discovery project quicker than synthetic dead-ends. Medicinal chemists face relentless timelines and shifting targets, so flexibility matters. 2-Bromo-3-Chloro-5-Fluorotoluene is a workhorse because it acts as a controlled branching point. By keeping reactive sites apart, the molecule supports iterative modifications and scare resources go further, reducing the need for extra protection and deprotection steps—the pain of every pharma scale-up.
Using compounds like this also keeps regulatory agencies satisfied—at least as much as possible—since cleaner, more selective routes cut out problematic impurities. Evidence from published studies points to better yields for fluorinated derivatives, which in turn can lower costs by reducing labor and solvent waste. This compound’s popularity isn’t just a matter of baseline reactivity, but how it fits with real-world standards for safety and efficiency.
Chemists tend to remember setbacks more than victories. One pilot project relied on another polychlorinated toluene with poor reliability, tripping up yields at every scale. Switching to this specific bromo-chloro-fluoro pattern took frustration out of routine processes. Batch-to-batch consistency stayed high, columns ran cleaner, and downstream purification drew fewer complaints. In high-throughput settings, that means confidence to push forward on tough timelines.
Industry adoption has further ripple effects. Suppliers invest in tighter controls, upstream source materials get scrutinized for contaminants, and analytical teams build more robust QC methods. Reports from leading chemical suppliers show upward trends in research usage, particularly where SAR (structure-activity relationship) work circles around fluoroaromatics. My experience tracking molecule fate in exploratory toxicology also confirmed—bromo-chloro-fluoro patterns bring down risky side-metabolites, adding a small but meaningful layer of assurance for project teams.
Not every lab stocks these materials, and some teams run up against sourcing obstacles. High demand for advanced halogenated aromatics pushes up lead times, which matters most during crunch moments for grant deadlines or product launches. Large-scale applications must watch for cost spikes because halogenated intermediates mean hazardous waste concerns, both from a legal and practical standpoint. Enough labs have found themselves on the wrong side of environmental audits; reliable vendors earn trust by making disposal straightforward and supporting compliance documentation, though the onus always stays with the user.
Handling, too, calls for respect. Like all halogenated organics, exposure risks can’t be ignored, especially with volatility and toxicity beyond basic hydrocarbon solvents. My rule: gloves, well-ventilated hood, and storage under strict inventory tracking. Even seasoned chemists have stories about near-misses—the stakes only go up with more specialized chemicals. Quality oversight on glassware and tracking, as much as chemical technique, contributes to safe workflows.
Advanced intermediates shape not only the science, but the environmental footprint. Regulators want tighter limits on persistent organic pollutants—a category that can include many halogenated organics. The pressure to develop greener routes runs high, especially in Europe and increasingly in Asia-Pacific labs. Leaders in synthetic chemistry are taking cues, designing new processes that harness these halogenated building blocks while minimizing byproducts. My own readings point to improved catalyst systems and aqueous-phase couplings that lessen reliance on hazardous reagents, helping to clear regulatory hurdles and keep downstream liabilities in check.
Stakeholders don’t separate process from principle. Research groups and suppliers that invest in improving synthetic efficiency set a stronger foundation for their field. Long-term, chemistry benefits from this mutual accountability—cutting down on hazardous waste, supporting clear audits, and making supply chains easier to trace.
As fields like material science and fine chemicals continue to expand, compounds like 2-Bromo-3-Chloro-5-Fluorotoluene rise in relevance. Beyond established pharma and agrochemical uses, innovators tap into its halogen-rich structure to design advanced polymers, molecular tags for spectral analysis, and components in organic electronics. Research literature points to its utility in arylation reactions, while emerging patents describe fluoroaromatic scaffolds for specialty coatings and imaging agents. It’s worth noting that structure-driven selectivity remains central: the tri-halogen combination streamlines access to otherwise hard-to-make motifs, establishing a feedback loop between invention and practical synthesis.
Innovation thrives when researchers have reliable, flexible building blocks. This compound delivers, supporting not only the conventional cross-couplings but site-selective modifications that can unlock entirely new branches of small molecule chemistry. Success stories often start with a single, well-chosen intermediate, clearing the path for high-impact results.
Those outside the lab might see reagent shopping as a simple process, but the reality looks different—especially for advanced halogenated aromatics. Price volatility, supply bottlenecks for precursors, and logistical snags hit hard when production lines or grant schedules hang in the balance. Buying cheap can backfire fast: I’ve learned the hard way that a “deal” on low-purity stock means double-work in purification or worse, wasted months resolving contamination.
For sustained operations, the market rewards suppliers that publish batch-level data, disclose synthetic routes, and integrate upstream controls against known contamination points. Transparency alone doesn’t shield against raw material shortages, so strong relationships matter. Teams planning for resilience factor in buffer stocks and qualify material from more than one supplier, safeguarding against disruption. In my years collaborating with purchasing and QA teams, the clearest results come from matching technical expertise with supply chain vigilance.
Moving from catalog to benchtop, tangible differences mark quality reagents. 2-Bromo-3-Chloro-5-Fluorotoluene often pours clear, with a faint, halogen odor that signals both potency and purity. Each shipment’s testing brings a little anxiety, which fades when NMR spectra snap into line and reaction setups run without hiccups. Reliable compounds literally save time and energy—graduate researchers know every clean reaction means one less weekend spent rerunning columns.
The learning curve is real. Mistakes—like miscounting equivalents or underestimating volatility—can sideline projects. Mentorship helps, but so do supplier technical teams, who can cut through confusion about optimal storage or best solvents for workup. As collaborations across industries and continents become the norm, standardized lots and clear, reproducible outcomes mean more than convenience; they build the trust on which bigger discoveries depend.
With pressure mounting to balance innovation against environmental responsibility, specialty intermediates like this one face their own evolution. Forward-thinking groups invest in catalysis research that shapes halogenation steps more cleanly. Flow chemistry, smart batch monitoring, and solvent recycling all play into making synthesis both leaner and greener. Some industrial partners already push toward biocatalytic steps, aiming to swap petroleum-derived precursors for renewable feedstocks. Whether every approach works in practice is still unsettled, but the trend is clear: tomorrow’s building blocks must hit performance marks without crossing regulatory red lines.
Effective solutions emerge from partnership. Chemists, suppliers, and regulatory teams each play a piece in developing better routes and safer handling practices. A willingness to share know-how—across publications, at conferences, in open-source lab groups—accelerates adoption of smarter ways to use and produce advanced aromatics.
Ultimately, the strength of a specialty intermediate like 2-Bromo-3-Chloro-5-Fluorotoluene lies in its ability to empower creativity without becoming a bottleneck for safety, scale, or sustainability. By supporting rigorous new synthesis strategies, the compound helps researchers claim new ground—whether unlocking next-generation medicines or smarter agrochemicals. The bridge from lab-scale curiosity to robust, scalable production rests on consistent quality and predictive performance.
To keep pace with rising standards, industry and academia must keep investing in purity testing, green process improvements, and strategic sourcing. The heart of progress comes not only from breakthrough science but from the reliable infrastructure that supports it. My experience in the lab and on the procurement side confirms it: the pathway from a well-chosen, tightly specified building block can change the entire shape of a research program. Those small details—positioning of a bromo, a chloro, and a fluoro—hold sway over the possibilities of tomorrow’s molecules.